Social and economic pressures have long compelled Black girls and women to straighten their hair. But mounting evidence shows chemical straighteners may pose cancer and other health risks.
A new analysis found that relapse-free survival is a poor surrogate endpoint for overall survival in adjuvant immunotherapy trials in a variety of cancer types.
Conclusions from the first interim analysis of overall survival in the IMpower010 trial of adjuvant atezolizumab for non–small cell lung cancer has been met with some pushback.
First-line atezolizumab monotherapy was associated with improved overall survival and maintenance of quality of life compared with single-agent chemotherapy for patients with advanced NSCLC.
However, a post-hoc analysis adds to evidence suggesting that irradiating all metastatic lesions may improve survival in patients receiving immune checkpoint inhibitor monotherapy.